Skip to content
10-K/A

Annual Report

SANGUI BIOTECH INTERNATIONAL INC

0001551163-21-000017

← back to feed
Filed
Apr 30, 2021 12:00 AM ET
Period of report
Amendment. Amends a previously filed report.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2020 · Sep 30, 2020 203.3M sh
Operating Cash Flow FY 2020 · Jun 30, 2020 −$168.39K
Operating Cash Flow FY 2020 · Jun 30, 2019 −$316.92K
Short Term Debt FY 2020 · Jun 30, 2020 $618.57K
Short Term Debt FY 2020 · Jun 30, 2019 $478.36K
Cash And Equivalents FY 2020 · Jun 30, 2020 $15.28K
Cash And Equivalents FY 2020 · Jun 30, 2019 $27.45K
Cash And Equivalents FY 2020 · Jun 30, 2018 $20.94K
Stockholders Equity FY 2020 · Jun 30, 2020 −$82.9K
Stockholders Equity FY 2020 · Jun 30, 2019 $49.2K
Current Liabilities FY 2020 · Jun 30, 2020 $791.49K
Current Liabilities FY 2020 · Jun 30, 2019 $670.96K
Total Liabilities FY 2020 · Jun 30, 2020 $855.21K
Total Liabilities FY 2020 · Jun 30, 2019 $670.96K
Current Assets FY 2020 · Jun 30, 2020 $48.7K
Current Assets FY 2020 · Jun 30, 2019 $78.97K
Total Assets FY 2020 · Jun 30, 2020 $125.33K
Total Assets FY 2020 · Jun 30, 2019 $78.97K
Sga Expense FY 2020 · Jun 30, 2020 $39.75K
Sga Expense FY 2020 · Jun 30, 2019 $188.89K
Rd Expense FY 2020 · Jun 30, 2020 $8.31K
Rd Expense FY 2020 · Jun 30, 2019 $27.23K
Net Income FY 2020 · Jun 30, 2020 −$192.74K
Net Income FY 2020 · Jun 30, 2019 −$323.58K
Operating Income FY 2020 · Jun 30, 2020 −$181.39K
Operating Income FY 2020 · Jun 30, 2019 −$337.64K
Gross Profit FY 2020 · Jun 30, 2020 $28.92K
Gross Profit FY 2020 · Jun 30, 2019 $88K
Revenue FY 2020 · Jun 30, 2020 $28.92K
Revenue FY 2020 · Jun 30, 2019 $88K